X0306 4 2023-03-06 0 0001642380 Oncocyte Corp OCX 0001590144 PURA VIDA INVESTMENTS, LLC 512 W 22ND STREET 7TH FLOOR NEW YORK NY 10011 0 0 1 0 0001789193 Kamen Efrem C/O PURA VIDA INVESTMENTS, LLC 512 W 22ND STREET, 7TH FLOOR NEW YORK NY 10011 0 0 1 0 Common Stock 2023-03-06 4 J 0 3890111 D 4589571 I By the Managed Accounts. Common Stock 767952 I By Pura Vida X Fund LP Common Stock 1381438 I By the Retirement Trust Common Stock 7427202 I By Pura Vida Master Fund, Ltd. As of March 6, 2023, the Reporting Persons no longer have voting and dispositive power for certain Managed Accounts and therefore such shares are no longer deemed beneficially owned by the Reporting Persons. Not applicable. Shares reported herein are owned by Pura Vida Master Fund, Ltd., Pura Vida X Fund LP, and Lockheed Martin Corporation Master Retirement Trust (the "Retirement Trust") and certain separately managed accounts (the "Managed Accounts" and collectively, the "Client Accounts"). Pura Vida Investments, LLC ("PVI") serves as the investment manager or sub-adviser to the Client Accounts. Efrem Kamen serves as the Managing Member of PVI. By virtue of these relationships, the Reporting Persons may be deemed to have shared voting and dispositive power with respect to the securities owned directly by the Client Accounts. This report shall not be deemed an admission that the Reporting Persons are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of the Reporting Person's pecuniary interest therein, if any. /s/ Efrem Kamen, Managing Member of Pura Vida Investments, LLC 2023-03-08 /s/ Efrem Kamen 2023-03-08